Zobrazeno 1 - 10
of 118
pro vyhledávání: '"Heribert, Hänscheid"'
Publikováno v:
Zeitschrift für Medizinische Physik, Vol 33, Iss 1, Pp 82-90 (2023)
In radionuclide therapy, activity kinetics in tissues determine the absorbed doses administered and thus efficacy and side effects of treatment. The objective of this work was to derive expressions for the parameters affecting the absorbed dose to a
Externí odkaz:
https://doaj.org/article/64404469bc3b4777aa59a62a9eae7b20
Autor:
Philipp E. Hartrampf, Heribert Hänscheid, Olivia Kertels, Andreas Schirbel, Michael C. Kreissl, Michael Flentje, Reinhart A. Sweeney, Andreas K. Buck, Bülent Polat, Constantin Lapa
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss , Pp 29-32 (2020)
Background: The combination of somatostatin receptor-directed peptide receptor radionuclide therapy (PRRT) in combination with external beam radiotherapy (EBRT) might prove a feasible treatment option in patients with advanced meningioma. Patients an
Externí odkaz:
https://doaj.org/article/7e0e23e45fa0499f823601e14fe386bd
Autor:
Andreas K. Buck, Götz Ulrich Grigoleit, Sabrina Kraus, Andreas Schirbel, Michael Heinsch, Niklas Dreher, Takahiro Higuchi, Constantin Lapa, Heribert Hänscheid, Samuel Samnick, Hermann Einsele, Sebastian E. Serfling, Rudolf A. Werner
Publikováno v:
J Nucl Med
C-X-C motif chemokine receptor 4 (CXCR4)–targeted radioligand therapy (RLT) has already been applied to advanced blood cancers, such as multiple myeloma or diffuse large B-cell lymphoma. We present a series of patients with advanced T-cell lymphoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::481dc738a6ebc26ed5c22f13a3691d5e
https://doi.org/10.2967/jnumed.122.264207
https://doi.org/10.2967/jnumed.122.264207
Autor:
Andreas K. Buck, Sebastian E. Serfling, Thomas Lindner, Heribert Hänscheid, Andreas Schirbel, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Rudolf A. Werner
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 49:4133-4144
A growing body of literature reports on the upregulation of C-X-C motif chemokine receptor 4 (CXCR4) in a variety of cancer entities, rendering this receptor as suitable target for molecular imaging and endoradiotherapy in a theranostic setting. For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9985793e43ad015b27f95bc3866bf1d
https://doi.org/10.1007/s00259-022-05849-y
https://doi.org/10.1007/s00259-022-05849-y
Autor:
Andreas K. Buck, Takahiro Higuchi, Heribert Hänscheid, Alexander Weich, Constantin Lapa, Rudolf A. Werner, Natalie Hasenauer
Publikováno v:
Der Nuklearmediziner. 44:334-343
ZusammenfassungNeuroendokrine Neoplasien (NEN) stellen ein komplexes, heterogenes Krankheitsbild dar, wobei der Primärtumorlokation meist im Gastrointestinaltrakt lokalisiert ist. Als „Orphan Disease“ sind NEN zwar selten, werden aber primär du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b153fb9ed6166964c76c11854c1a39cd
https://doi.org/10.1055/a-1556-8323
https://doi.org/10.1055/a-1556-8323
Autor:
Rudolf A. Werner, Cyrus Sayehli, Heribert Hänscheid, Takahiro Higuchi, Sebastian E. Serfling, Martin Fassnacht, Maria-Elisabeth Goebeler, Andreas K. Buck, Matthias Kroiss
Publikováno v:
European journal of nuclear medicine and molecular imaging.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc92f5095c03fc6cf7aeae7de4c757e6
https://pubmed.ncbi.nlm.nih.gov/36522435
https://pubmed.ncbi.nlm.nih.gov/36522435
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 48:2566-2572
Purpose The radiolabelled somatostatin analogue [177Lu]Lu-DOTA-EB-TATE binds to albumin via Evans blue, thereby increasing the residence time in the blood and potentially allowing more therapeutic agent to be absorbed into the target tissue during pe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ccb8d8dbb79ed7afcd8ece55b8d367
https://doi.org/10.1007/s00259-020-05177-z
https://doi.org/10.1007/s00259-020-05177-z
Autor:
Olivia Kertels, Constantin Lapa, Michael Flentje, Michael C. Kreissl, Philipp E. Hartrampf, Heribert Hänscheid, Bülent Polat, Andreas Schirbel, Andreas K. Buck, Reinhart A. Sweeney
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 22, Iss, Pp 29-32 (2020)
Clinical and Translational Radiation Oncology
Clinical and Translational Radiation Oncology
Highlights • Combination of PRRT and EBRT is feasible and safe in meningioma. • Combined therapy resulted in disease stabilization in 7 of 10 patients. • Future prospective validation of this new approach in larger cohorts is warranted.
Ba
Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a60b4f919165d1efc7193cc5ed48a91
https://doi.org/10.1016/j.ctro.2020.03.002
https://doi.org/10.1016/j.ctro.2020.03.002
Autor:
Michael Lassmann, Heribert Hänscheid
Publikováno v:
Handbook of Nuclear Medicine and Molecular Imaging for Physicists ISBN: 9780429489549
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c2b59ecaae2221ee03c42946e3e5c97
https://doi.org/10.1201/9780429489549-13
https://doi.org/10.1201/9780429489549-13
Autor:
Seval Beykan, Heribert Hänscheid, Andreas Schirbel, Stefanie Hahner, Andreas K. Buck, Michael Lassmann
Publikováno v:
Physica Medica. 104:S100
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c63ea426eada6ad039bcb4dc38ef2cf6
https://doi.org/10.1016/s1120-1797(22)02350-x
https://doi.org/10.1016/s1120-1797(22)02350-x